309 results on '"Baekelandt V"'
Search Results
2. ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
3. Reactive neural stem cells in the adult hippocampus: S30-01
4. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
5. Oncostatin m-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination
6. Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors
7. Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9
8. In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma
9. Long-term effect of chemogenetic suppression of excitatory hippocampal neurons on spontaneous seizures in a rat model for temporal lobe epilepsy
10. α-Synuclein strains influence multiple system atrophy via central and peripheral mechanisms
11. Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain
12. Interleukin-6 class cytokines regulate the development of inflammatory CNS lesions: W14.001
13. A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinsonʼs disease
14. Insult-induced aberrant hippocampal neurogenesis: Functional consequences and possible therapeutic strategies
15. Rab8 and Rab10 phosphorylation contribute to LRRK2-mediated centrosomal cohesion and ciliogenesis defects
16. -Synuclein strains cause distinct synucleinopathies after local and systemic administration
17. Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
18. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and CF Mice
19. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function
20. Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
21. Retinal α -synucleinopathy: taking a new look at Parkinson's disease
22. Levodopa gains psychostimulant-like properties after nigral dopaminergic loss
23. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein
24. WS01.1 rAAV2/5 encoding a truncated CFTR rescues the CF phenotype in intestinal organoids and a CF mouse model
25. WS1.4 A rAAV2/5 based gene therapy model for cystic fibrosis airway disease
26. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
27. PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A COVALENTLY BOUND P2- substituted N-acyl-prolylpyrrolidine inhibitor
28. PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN WITH A NON-COVALENTLY BOUND P2-substituted N-acyl-prolylpyrrolidine inhibitor
29. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains
30. A mathematical model of adult subventricular neurogenesis
31. On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
32. Alterations in GAP-43 and synapsin immunoreactivity provide evidence for synaptic reorganization in adult cat dLGN following retinal lesions
33. Inhibition of FK506 Binding Proteins Reduces -Synuclein Aggregation and Parkinson's Disease-Like Pathology
34. Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
35. In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma
36. 2.013 Cellular and biochemical study of LRRK2 ROC GTPase domain
37. 2.113 A role for PINK1 in mitochondrial dynamics and mitochondrial function
38. Current Gene Therapy
39. Alterations in GAP‐43 and Synapsin Immunoreactivity Provide Evidence for Synaptic Reorganization in Adult Cat Dorsal Lateral Geniculate Nucleus following Retinal Lesions
40. A prolyl oligopeptidase inhibitor, KYP-2047, reduces [alpha]-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.
41. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.
42. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
43. Long-term effects of retinal lesions on growth-associated protein 43 (GAP-43) expression in the visual system of adult cats
44. Transgenic mice expressing an a-secretion mutant of the amyloid precursor protein in the brain develop a progressive CNS disorder
45. NEUROPOIETIC CYTOKINES REGULATE THE DEVELOPMENT OF INFLAMMATORY CNS LESIONS
46. COMBINED IN VIVO BIOLUMINESCENCE AND MAGNETIC RESONANCE IMAGING OF ADHERENTLY CULTURED NEURAL STEM/PROGENITOR CELL IMPLANTS IN BRAIN OF MICE
47. Oncostatin M signaling is essential for robust remyelination
48. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors
49. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein
50. Magnetic resonance imaging and spectroscopy methods for molecular imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.